This activity is intended for cardiologists, family medicine/primary care clinicians, internists, psychiatrists, neurologists, nurses/nurse practitioners, physician assistants, and other members of the healthcare team for patients with depression who may be at increased risk for stroke.
The goal of this activity is for learners to be better able to describe the trajectory of depressive symptoms several years before and after incident stroke, measured with the Center for Epidemiologic Studies Depression Scale (CES-D 8), according to an analysis of data from the English Longitudinal Study of Ageing (ELSA).
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 9/9/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 9/9/2022
Valid for credit through: 9/9/2023, 11:59 PM EST
processing....
Depression is common among patients with stroke, with cumulative incidence 39% to 52% within 5 years of stroke and risk 2- to 8-fold higher than in a reference population; however, depressive symptom trajectories before and after stroke are still unclear.
Although increased depressive symptoms after stroke may reflect psychological reaction to stroke and associated disability, or stroke-induced brain damage, high depression rates among stroke survivors may partly reflect changes preceding stroke. Recent studies have shown depression to be an independent risk factor for stroke incidence.
Whereas symptoms of depression are known to intensify in patients who have recently experienced an incident stroke, it might also be true in such cases that the depression actually starts to worsen in the months or years before the stroke occurs, suggests a new study of adults 50 years and older.
"Stroke seems to alter the course of depressive symptoms in more complex ways than previously thought," Maria Blöchl, PhD, University of Münster, Germany, told Medscape Medical News.
"As commonly thought, depressive symptoms surge after stroke and remain elevated for several years. But we also showed that depressive symptoms slightly increase before the stroke, perhaps indicating incipient stroke," said Blöchl, who is lead author on the study published online July 13 in Neurology, with coauthor Steffen Nestler, PhD, also from the University of Münster.
Prestroke and Poststroke DepressionAbout 30% of stroke survivors might experience depression at any time after the acute event. The cumulative incidence within 5 years hovers around 39% to 52%, yet little is known about how changes in depressive symptoms unfold before and after incident stroke, the report states.
To investigate, Blöchl and colleagues identified the trajectory of depressive symptoms several years before and after incident stroke in 10,797 adults (mean age, 65 years; 55% women) from the English Longitudinal Study of Ageing (ELSA), an ongoing longitudinal cohort study.
The 425 case participants (3.9%) who experienced an incident stroke during a 12-year follow-up period were propensity-score matched with 4249 stroke-free individuals.
Every 2 years in the study, participants reported past-week depressive symptoms using the 8-item version of the widely used Center for Epidemiologic Studies Depression Scale (CES-D 8), in which higher scores on a 0- to 8-point scale indicate more depressive symptoms. For this study, a CES-D 8 score of at least 3 was used to indicate probable depression.
Starting about 2 years before stroke onset, the severity of depressive symptoms increased by an average of 0.33 points (P < .001), with a further increase of 0.23 points after stroke (P < .001). Depressive symptoms remained elevated for 10 years after stroke.
In contrast, the group reports, depressive symptoms remained relatively stable over time in stroke-free individuals.
There was no statistically significant difference in prevalence of probable depression at the 2-year prestroke assessment among persons with and without stroke (29% vs 24%). At the time of stroke, however, probable depression was significantly more common in the stroke group (34% vs 24%; P < .001), a difference that persisted at the 6-year assessment.
A Predictive Marker?Blöchl cautioned that rising symptoms of depression before stroke are mostly subtle and might not always be clinically detectable, and it remains unclear whether such prestroke changes can be used to predict who will have a stroke, "[but even slight increases in depressive symptoms, especially mood and fatigue-related symptoms, may be a signal a stroke that is about to occur."
The clinical implications of the current findings remain unclear, she noted.
"It could be envisioned that stroke might be predicted from prestroke symptoms -- depressive, cognitive, physical -- in combination with classical vascular risk factors, but that requires further research," Blöchl told Medscape Medical News.
"Depression has long been known to follow a stroke, especially in the early months of a brain attack," Shaheen E. Lakhan, MD, PhD, a neurologist and researcher from Boston, who wasn't involved in the analysis, told Medscape Medical News.
"Newer lines of research are now showing depression itself as a risk factor for stroke," and the current study is consistent with that, he added.
Lakhan noted cited a few caveats to the analysis, however. The subjects were assessed only every 2 years "and with a depression screening tool, not diagnostic assessment," limiting our ability to draw strong conclusions.
Nonetheless, Lakhan said, the data "underscore the importance of early recognition and management of depression especially as we age."
Blöchl, Nestler, and Lakhan report no relevant disclosures.
Neurology. Published online July 13, 2022.[1]